HemaSphere (May 2023)

P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER EXPOSURE TO NON-CELLULAR ANTI-B-CELL MATURATION ANTIGEN (BCMA) IMMUNOTHERAPY

  • N. van de Donk,
  • M.-V. Mateos,
  • Y.C. Cohen,
  • P. Rodriguez-Otero,
  • B. Paiva,
  • A.D. Cohen,
  • T. Martin,
  • A. Suvannasankha,
  • D. Madduri,
  • C. Corsale,
  • J.M. Schecter,
  • K.C. De Braganca,
  • C.C. Jackson,
  • H. Varsos,
  • W. Deraedt,
  • T. Roccia,
  • P. Mistry,
  • X. Xu,
  • K. Li,
  • E. Zudaire,
  • M. Akram,
  • L. Pacaud,
  • I. Avivi,
  • J. San-Miguel

DOI
https://doi.org/10.1097/01.HS9.0000936240.43628.7e
Journal volume & issue
Vol. 7, no. S2
pp. 25 – 26

Abstract

Read online

No abstracts available.